| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia SE Maynard, JY Min, J Merchan, KH Lim, J Li, S Mondal, TA Libermann, ... The Journal of clinical investigation 111 (5), 649-658, 2003 | 5184 | 2003 |
| Circulating angiogenic factors and the risk of preeclampsia RJ Levine, SE Maynard, C Qian, KH Lim, LJ England, KF Yu, ... New England journal of medicine 350 (7), 672-683, 2004 | 4646 | 2004 |
| Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice MA Brown, LA Magee, LC Kenny, SA Karumanchi, FP McCarthy, S Saito, ... Hypertension 72 (1), 24-43, 2018 | 2752 | 2018 |
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia RJ Levine, C Lam, C Qian, KF Yu, SE Maynard, BP Sachs, BM Sibai, ... New England Journal of Medicine 355 (10), 992-1005, 2006 | 2516 | 2006 |
| Soluble endoglin contributes to the pathogenesis of preeclampsia S Venkatesha, M Toporsian, C Lam, J Hanai, T Mammoto, YM Kim, ... Nature medicine 12 (6), 642-649, 2006 | 2446 | 2006 |
| Preeclampsia: pathophysiology, challenges, and perspectives S Rana, E Lemoine, JP Granger, SA Karumanchi Circulation research 124 (7), 1094-1112, 2019 | 1905 | 2019 |
| Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease CE Powe, RJ Levine, SA Karumanchi Circulation 123 (24), 2856-2869, 2011 | 1347 | 2011 |
| Vitamin D–binding protein and vitamin D status of black Americans and white Americans CE Powe, MK Evans, J Wenger, AB Zonderman, AH Berg, M Nalls, ... New England Journal of Medicine 369 (21), 1991-2000, 2013 | 1242 | 2013 |
| Pre-eclampsia: pathogenesis, novel diagnostics and therapies EA Phipps, R Thadhani, T Benzing, SA Karumanchi Nature Reviews Nephrology 15 (5), 275-289, 2019 | 1131 | 2019 |
| Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis C Wei, S El Hindi, J Li, A Fornoni, N Goes, J Sageshima, D Maiguel, ... Nature medicine 17 (8), 952-960, 2011 | 1007 | 2011 |
| Pathogenesis of preeclampsia BC Young, RJ Levine, SA Karumanchi Annual Review of Pathology: Mechanisms of Disease 5 (1), 173-192, 2010 | 996 | 2010 |
| A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal … R Romero, JK Nien, J Espinoza, D Todem, W Fu, H Chung, JP Kusanovic, ... The journal of maternal-fetal & neonatal medicine 21 (1), 9-23, 2008 | 923 | 2008 |
| Preeclampsia: the role of angiogenic factors in its pathogenesis A Wang, S Rana, SA Karumanchi Physiology 24 (3), 147-158, 2009 | 846 | 2009 |
| Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia S Rana, CE Powe, S Salahuddin, S Verlohren, FH Perschel, RJ Levine, ... Circulation 125 (7), 911-919, 2012 | 807 | 2012 |
| Angiogenic factors and preeclampsia SE Maynard, SA Karumanchi Seminars in nephrology 31 (1), 33-46, 2011 | 680 | 2011 |
| Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia C Lam, KH Lim, SA Karumanchi Hypertension 46 (5), 1077-1085, 2005 | 674 | 2005 |
| First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia R Thadhani, WP Mutter, M Wolf, RJ Levine, RN Taylor, VP Sukhatme, ... The Journal of Clinical Endocrinology & Metabolism 89 (2), 770-775, 2004 | 637 | 2004 |
| Cardiac angiogenic imbalance leads to peripartum cardiomyopathy IS Patten, S Rana, S Shahul, GC Rowe, C Jang, L Liu, MR Hacker, ... Nature 485 (7398), 333-338, 2012 | 622 | 2012 |
| Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans SM Parikh, T Mammoto, A Schultz, HT Yuan, D Christiani, SA Karumanchi, ... PLoS medicine 3 (3), e46, 2006 | 614 | 2006 |
| Molecular mechanisms of preeclampsia WP Mutter, SA Karumanchi Microvascular research 75 (1), 1-8, 2008 | 558 | 2008 |
